Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression

Nature Genetics

Volumn 38, Issue 5, 2006, Pages 531-539

  Babitt, Jodie L ^a   Huang, Franklin W ^b   Wrighting, Diedra M ^b   Xia, Yin ^a   Sidis, Yisrael ^a   Samad, Tarek A ^a   Campagna, Jason A ^a   Chung, Raymond T ^a   Schneyer, Alan L ^a   Woolf, Clifford J ^a   Andrews, Nancy C ^b,c   Lin, Herbert Y ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HEMOJUVELIN; HEPCIDIN;

ANEMIA; ANIMAL CELL; ARTICLE; ERYTHROPOIESIS; GENETIC CODE; HEMOCHROMATOSIS; INTERNALIZATION; INTESTINE ABSORPTION; IRON METABOLISM; IRON OVERLOAD; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS REGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MORPHOGENETIC PROTEINS; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; HUMANS; LIVER; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 33646370235     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1777     Document Type: Article

References (50)

1. Hentze, M.W., Muckenthaler, M.U. & Andrews, N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285-297 (2004).
2. Krause, A. et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480, 147-150 (2000).
3. Park, C.H., Valore, E.V., Waring, A.J. & Ganz, T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806-7810 (2001).
4. Pigeon, C. et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819 (2001).
5. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093 (2004).
6. Nicolas, G. et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780-8785 (2001).
7. Roetto, A. et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21-22 (2003).
8. Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044 (2002).
9. Lee, P., Peng, H., Gelbart, T., Wang, L. & Beutler, E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. USA 102, 1906-1910 (2005).
10. Nemeth, E. et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461-2463 (2003).
11. Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276 (2004).
12. Papanikolaou, G. et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36, 77-82 (2004).
13. Lanzara, C. et al. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103, 4317-4321 (2004).
14. Lee, P.L., Beutler, E., Rao, S.V. & Barton, J.C. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 103, 4669-4671 (2004).
15. Huang, F.W., Rubio-Aliaga, I., Kushner, J.P., Andrews, N.C. & Fleming, M.D. Identification of a novel mutation (C321X) in HJV. Blood 104, 2176-2177 (2004).
16. Samad, T.A. et al. DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. J. Neurosci. 24, 2027-2036 (2004).
17. Niederkofler, V., Salie, R., Sigrist, M. & Arber, S. Repulsive guidance molecule (RGM) gene function is required for neural tube closure but not retinal topography in the mouse visual system. J. Neurosci. 24, 808-818 (2004).
18. Rodriguez Martinez, A., Niemela, O. & Parkkila, S. Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin. Haematologica 89, 1441-1445 (2004).
19. Huang, F.W., Pinkus, J.L., Pinkus, G.S., Fleming, M.D. & Andrews, N.C. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 115, 2187-2191 (2005).
20. Niederkofler, V., Salie, R. & Arber, S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest. 115, 2180-2186 (2005).
21. Lin, L., Goldberg, Y.P. & Ganz, T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106, 2884-2889 (2005).
22. Monnier, P.P. et al. RGM is a repulsive guidance molecule for retinal axons. Nature 419, 392-395 (2002).
23. Zhang, A.S., West, A.P. Jr, Wyman, A.E., Bjorkman, P.J. & Enns, C.A. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J. Biol. Chem. 280, 33885-33894 (2005).
24. Samad, T.A. et al. DRAGON, a bone morphogenetic protein co-receptor. J. Biol. Chem. 280, 14122-14129 (2005).
25. Babitt, J.L. et al. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J. Biol. Chem. 280, 29820-29827 (2005).
26. Shi, Y. & Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003).
27. Hogan, B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594 (1996).
28. Zhao, G.Q. Consequences of knocking out BMP signaling in the mouse. Genesis 35, 43-56 (2003).
29. Balemans, W. & Van Hul, W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250, 231-250 (2002).
30. Wang, R.-H. et al. A role of SMAD4 in iron metabolism through positive regulation of hepcidin expression. Cell Metab. 2, 399-409 (2005).
31. Korchynskyi, O. & ten Dijke, P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891 (2002).
32. Dennler, S. et al. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100 (1998).
33. Groppe, J. et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420, 636-642 (2002).
34. Clarke, T. R. et al. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol. Endocrinol. 15, 946-959 (2001).
35. Macias-Silva, M., Hoodless, P.A., Tang, S.J., Buchwald, M. & Wrana, J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273, 25628-25636 (1998).
36. Piscione, T.D., Phan, T. & Rosenblum, N.D. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. Am. J. Physiol. Renal Physiol. 280, F19-F33 (2001).
37. De Bleser, P.J., Niki, T., Rogiers, V. & Geerts, A. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J. Hepatol. 26, 886-893 (1997).
38. Kingsley, D.M. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet. 10, 16-21 (1994).
39. Knittel, T., Fellmer, P., Muller, L. & Ramadori, G. Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and up-regulated by transforming growth factor-beta 1. Exp. Cell Res. 232, 263-269 (1997).
40. Miller, A.F., Harvey, S.A., Thies, R.S. & Olson, M.S. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J. Biol. Chem. 275, 17937-17945 (2000).
41. Kanzler, S. et al. Hepatocellular expression of a dominant negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis. Oncogene 20, 5015-5024 (2001).
42. Krijt, J., Vokurka, M., Chang, K.T. & Necas, E. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 104, 4308-4310 (2004).
43. Alpini, G., Phillips, J.O., Vroman, B. & LaRusso, N.F. Recent advances in the isolation of liver cells. Hepatology 20, 494-514 (1994).
44. Rajagopalan, S. et al. Neogenin mediates the action of repulsive guidance molecule. Nat. Cell Biol. 6, 756-762 (2004).
45. Matsunaga, E. et al. RGM and its receptor neogenin regulate neuronal survival. Nat. Cell Biol. 6, 749-755 (2004).
46. Courselaud, B. et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277, 41163-41170 (2002).
47. del Re, E., Babitt, J.L., Pirani, A., Schneyer, A.L. & Lin, H.Y. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. J. Biol. Chem. 279, 22765-22772 (2004).
48. Frolik, C.A., Wakefield, L.M., Smith, D.M. & Sporn, M.B. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J. Biol. Chem. 259, 10995-11000 (1984).
49. Lin, J. et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119, 121-135 (2004).
50. Alonso, S., Minty, A., Bourlet, Y. & Buckingham, M. Comparison of three actin- coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol. 23, 11-22 (1986).